BioCentury | Mar 26, 2007
Clinical News

OrthoDerm: Phase IIb started

...The company began a double-blind, placebo-controlled, dose-ranging Phase IIb trial in up to 164 patients. Cure Therapeutics Inc....
BioCentury | Mar 27, 2006
Company News

Cure Therapeutics management update

Cure Therapeutics Inc. , New York, N.Y. Business: Musculoskeletal Hired: Ronald Burch as CEO, formerly CEO of AlgoRx Pharmaceuticals Inc.; and Robert Ang as COO, formerly a senior associate at Carrot Capital Healthcare Ventures WIR Staff...
BioCentury | Mar 21, 2006
Company News

Cure names Burch CEO

...Musculoskeletal company Cure Therapeutics (New York, N.Y.) hired Ronald Burch as CEO. Previously, Burch was CEO of...
BioCentury | Sep 10, 2005
Clinical News

Basilea BAL8557 Phase II data

Basilea (SWX:BSLN) said BAL8557 met the primary endpoint of non-inferiority to fluconazole on endoscopically confirmed clinical cure in a Phase II trial to treat esophageal candidiasis. In the double-blind trial in 160 patients, confirmed clinical...
Items per page:
1 - 4 of 4
BioCentury | Mar 26, 2007
Clinical News

OrthoDerm: Phase IIb started

...The company began a double-blind, placebo-controlled, dose-ranging Phase IIb trial in up to 164 patients. Cure Therapeutics Inc....
BioCentury | Mar 27, 2006
Company News

Cure Therapeutics management update

Cure Therapeutics Inc. , New York, N.Y. Business: Musculoskeletal Hired: Ronald Burch as CEO, formerly CEO of AlgoRx Pharmaceuticals Inc.; and Robert Ang as COO, formerly a senior associate at Carrot Capital Healthcare Ventures WIR Staff...
BioCentury | Mar 21, 2006
Company News

Cure names Burch CEO

...Musculoskeletal company Cure Therapeutics (New York, N.Y.) hired Ronald Burch as CEO. Previously, Burch was CEO of...
BioCentury | Sep 10, 2005
Clinical News

Basilea BAL8557 Phase II data

Basilea (SWX:BSLN) said BAL8557 met the primary endpoint of non-inferiority to fluconazole on endoscopically confirmed clinical cure in a Phase II trial to treat esophageal candidiasis. In the double-blind trial in 160 patients, confirmed clinical...
Items per page:
1 - 4 of 4